{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T10:46:41Z","timestamp":1780051601135,"version":"3.53.1"},"reference-count":78,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T00:00:00Z","timestamp":1747267200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"MSD Pharma Hungary","award":["2022-2.1.1-NL-2022-00010"],"award-info":[{"award-number":["2022-2.1.1-NL-2022-00010"]}]},{"name":"MSD Pharma Hungary","award":["TKP2021-EGA-44"],"award-info":[{"award-number":["TKP2021-EGA-44"]}]},{"name":"National Research, Development, and Innovation Fund of the Ministry of Culture and Innovation under the National Laboratories Program (National Tumor Biology Laboratory","award":["2022-2.1.1-NL-2022-00010"],"award-info":[{"award-number":["2022-2.1.1-NL-2022-00010"]}]},{"name":"National Research, Development, and Innovation Fund of the Ministry of Culture and Innovation under the National Laboratories Program (National Tumor Biology Laboratory","award":["TKP2021-EGA-44"],"award-info":[{"award-number":["TKP2021-EGA-44"]}]},{"name":"Hungarian Thematic Excellence Program","award":["2022-2.1.1-NL-2022-00010"],"award-info":[{"award-number":["2022-2.1.1-NL-2022-00010"]}]},{"name":"Hungarian Thematic Excellence Program","award":["TKP2021-EGA-44"],"award-info":[{"award-number":["TKP2021-EGA-44"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Background: Assessing cancer survival trends is crucial for monitoring progress in cancer management and prevention. As part of the broader HUN-CANCER EPI study, this analysis examined overall survival (OS) in the Hungarian cancer population between 2011 and 2019. Methods: Using data extracted from the Hungarian National Health Insurance Fund (NHIF) database, short- and long-term OS were estimated for various cancer types according to age, sex, and diagnostic period using Kaplan\u2013Meier analysis. The study also identified cancer types with significant early mortality following diagnosis. Results: From 2011 to 2019, a total of 528,808 patients were diagnosed with cancer. During the 2015\u20132019 diagnostic period, the lowest 5-year OS rates were observed for esophageal (7.0%), pancreatic (10.7%), liver (12.5%), gallbladder (13.9%), and lung cancer (18.4%). Conversely, tumor types with better OS included testicular cancer (91.6%), thyroid cancer (89.0%), Hodgkin\u2019s lymphoma (84.0%), melanoma (78.6%), and breast cancer (74.1%). A notable proportion of deaths occurred within 2 months of diagnosis for liver (33.2%), pancreatic (27.9%), and gallbladder cancer (29.0%). Significant early mortality within 6 months post-diagnosis was also noted for esophageal (51.3%), stomach (42.9%), and lung cancer (41.7%). Conclusions: The HUN-CANCER EPI study conducted between 2011 and 2019 provides valuable insights into cancer survival patterns in Hungary, emphasizing the importance of early detection and targeted interventions to improve patient outcomes.<\/jats:p>","DOI":"10.3390\/cancers17101670","type":"journal-article","created":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T06:10:44Z","timestamp":1747289444000},"page":"1670","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Overall Survival of Hungarian Cancer Patients Diagnosed Between 2011 and 2019, Based on the Health Insurance Fund Database"],"prefix":"10.3390","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4752-8529","authenticated-orcid":false,"given":"Zolt\u00e1n","family":"Kiss","sequence":"first","affiliation":[{"name":"MSD Pharma Hungary Ltd., 1095 Budapest, Hungary"},{"name":"Second Department of Medicine and Nephrology-Diabetes Centre, University of P\u00e9cs Medical School, 7624 P\u00e9cs, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6944-2331","authenticated-orcid":false,"given":"Tam\u00e1s L\u00e1szl\u00f3","family":"Berki","sequence":"additional","affiliation":[{"name":"Center for Health Technology Assessment, Semmelweis University, 1085 Budapest, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2018-8413","authenticated-orcid":false,"given":"Anik\u00f3","family":"Mar\u00e1z","sequence":"additional","affiliation":[{"name":"Department of Oncotherapy, University of Szeged, 6720 Szeged, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5376-7737","authenticated-orcid":false,"given":"Zsolt","family":"Horv\u00e1th","sequence":"additional","affiliation":[{"name":"Department of Oncology, B\u00e1cs-Kiskun County Teaching Hospital, 6000 Kecskem\u00e9t, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3393-235X","authenticated-orcid":false,"given":"P\u00e9ter","family":"Nagy","sequence":"additional","affiliation":[{"name":"Department of Molecular Immunology and Toxicology, National Tumor Biology Laboratory, National Institute of Oncology, 1122 Budapest, Hungary"},{"name":"Department of Anatomy and Histology, HUN-REN\u2013UVMB Laboratory of Redox Biology Research Group, University of Veterinary Medicine, 1078 Budapest, Hungary"},{"name":"Chemistry Institute, University of Debrecen, 4032 Debrecen, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibolya","family":"F\u00e1bi\u00e1n","sequence":"additional","affiliation":[{"name":"RxTarget Ltd., 5000 Szolnok, Hungary"},{"name":"Department of Biostatistics, University of Veterinary Medicine, 1078 Budapest, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9ria","family":"Kov\u00e1cs","sequence":"additional","affiliation":[{"name":"RxTarget Ltd., 5000 Szolnok, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-0568-001X","authenticated-orcid":false,"given":"Gy\u00f6rgy","family":"Rokszin","sequence":"additional","affiliation":[{"name":"RxTarget Ltd., 5000 Szolnok, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5836-7647","authenticated-orcid":false,"given":"Gy\u00f6rgy","family":"Surj\u00e1n","sequence":"additional","affiliation":[{"name":"Department of Deputy Chief Medical Officer II., National Public Health Center, 1097 Budapest, Hungary"},{"name":"Institute of Digital Health Sciences, Semmelweis University, 1085 Budapest, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zs\u00f3fia","family":"Barcza","sequence":"additional","affiliation":[{"name":"Syntesia Medical Communications Ltd., 1065 Budapest, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6963-8489","authenticated-orcid":false,"given":"Istv\u00e1n","family":"Kenessey","sequence":"additional","affiliation":[{"name":"Hungarian National Cancer Registry and National Tumor Biology Laboratory, National Institute of Oncology, 1122 Budapest, Hungary"},{"name":"Department of Pathology, Forensic and Insurance Medicine, Semmelweis University, 1085 Budapest, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1605-8226","authenticated-orcid":false,"given":"Andr\u00e1s","family":"W\u00e9ber","sequence":"additional","affiliation":[{"name":"Hungarian National Cancer Registry and National Tumor Biology Laboratory, National Institute of Oncology, 1122 Budapest, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Istv\u00e1n","family":"Wittmann","sequence":"additional","affiliation":[{"name":"Second Department of Medicine and Nephrology-Diabetes Centre, University of P\u00e9cs Medical School, 7624 P\u00e9cs, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6052-5907","authenticated-orcid":false,"given":"Gerg\u0151 Attila","family":"Moln\u00e1r","sequence":"additional","affiliation":[{"name":"Second Department of Medicine and Nephrology-Diabetes Centre, University of P\u00e9cs Medical School, 7624 P\u00e9cs, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9745-6255","authenticated-orcid":false,"given":"Tam\u00e1s G.","family":"Szab\u00f3","sequence":"additional","affiliation":[{"name":"MSD Pharma Hungary Ltd., 1095 Budapest, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikt\u00f3ria","family":"Buga","sequence":"additional","affiliation":[{"name":"MSD Pharma Hungary Ltd., 1095 Budapest, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenia","family":"Karamousouli","sequence":"additional","affiliation":[{"name":"MSD Pharma Hungary Ltd., 1095 Budapest, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikl\u00f3s","family":"Darida","sequence":"additional","affiliation":[{"name":"MSD Pharma Hungary Ltd., 1095 Budapest, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5585-3313","authenticated-orcid":false,"given":"Zsolt","family":"Abonyi-T\u00f3th","sequence":"additional","affiliation":[{"name":"RxTarget Ltd., 5000 Szolnok, Hungary"},{"name":"Department of Biostatistics, University of Veterinary Medicine, 1078 Budapest, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren\u00e1ta","family":"Bert\u00f3kn\u00e9 Tam\u00e1s","sequence":"additional","affiliation":[{"name":"Department of Deputy Chief Medical Officer II., National Public Health Center, 1097 Budapest, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikt\u00f3ria Di\u00e1na","family":"F\u00fcrt\u0151s","sequence":"additional","affiliation":[{"name":"Department of Deputy Chief Medical Officer II., National Public Health Center, 1097 Budapest, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krisztina","family":"Bogos","sequence":"additional","affiliation":[{"name":"Directorate of Institution, National Kor\u00e1nyi Institute of Pulmonology, 1121 Budapest, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9425-1748","authenticated-orcid":false,"given":"Judit","family":"Moldvay","sequence":"additional","affiliation":[{"name":"1st Department of Pulmonology, National Kor\u00e1nyi Institute of Pulmonology, 1121 Budapest, Hungary"},{"name":"Department of Pulmonology, Albert Szent-Gy\u00f6rgyi Medical School, University of Szeged, 6720 Szeged, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"G\u00e1lffy","sequence":"additional","affiliation":[{"name":"Pulmonology Center of the Reformed Church in Hungary, Department of Pulmonology, 2045 T\u00f6r\u00f6kb\u00e1lint, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilla","family":"Tam\u00e1si","sequence":"additional","affiliation":[{"name":"Department of Pulmonology, Semmelweis University, 1085 Budapest, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1398-3187","authenticated-orcid":false,"given":"Veronika","family":"M\u00fcller","sequence":"additional","affiliation":[{"name":"Department of Pulmonology, Semmelweis University, 1085 Budapest, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2149-3935","authenticated-orcid":false,"given":"Zo\u00e1rd Tibor","family":"Krasznai","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Faculty of Medicine, University of Debrecen, 4032 Debrecen, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gyula","family":"Ostoros","sequence":"additional","affiliation":[{"name":"Directorate of Institution, National Kor\u00e1nyi Institute of Pulmonology, 1121 Budapest, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zsolt","family":"P\u00e1pai-Sz\u00e9kely","sequence":"additional","affiliation":[{"name":"Fej\u00e9r County Szent Gy\u00f6rgy, University Teaching Hospital, 8000 Sz\u00e9kesfeh\u00e9rv\u00e1r, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"Branyiczkin\u00e9 G\u00e9czy","sequence":"additional","affiliation":[{"name":"Demographic Statistics Department, Hungarian Central Statistical Office, 1024 Budapest, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00e1szl\u00f3n\u00e9","family":"Hilbert","sequence":"additional","affiliation":[{"name":"Demographic Statistics Department, Hungarian Central Statistical Office, 1024 Budapest, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Csaba","family":"Polg\u00e1r","sequence":"additional","affiliation":[{"name":"National Tumor Biology Laboratory, National Institute of Oncology, 1122 Budapest, Hungary"},{"name":"Department of Oncology, Semmelweis University, 1085 Budapest, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1004-1848","authenticated-orcid":false,"given":"Zolt\u00e1n","family":"Vok\u00f3","sequence":"additional","affiliation":[{"name":"Center for Health Technology Assessment, Semmelweis University, 1085 Budapest, Hungary"},{"name":"Syreon Research Institute, 1145 Budapest, Hungary"},{"name":"Center for Pharmacology and Drug Research & Development, Semmelweis University, 1085 Budapest, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,5,15]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S0140-6736(17)33326-3","article-title":"Global surveillance of trends in cancer survival 2000\u201314 (CONCORD-3): Analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries","volume":"391","author":"Allemani","year":"2018","journal-title":"Lancet"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Bovio, N., Grzebyk, M., Arveux, P., Bulliard, J.-L., Chiolero, A., Fournier, E., Germann, S., Konzelmann, I., Maspoli, M., and Rapiti, E. (2022). Work-Related Factors and Lung Cancer Survival: A Population-Based Study in Switzerland (1990\u20132014). Int. J. Environ. Res. Public Health, 19.","DOI":"10.3390\/ijerph192113856"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"102196","DOI":"10.1016\/j.canep.2022.102196","article-title":"World-wide trends in net survival from pancreatic cancer by morphological sub-type: An analysis of 1,258,329 adults diagnosed in 58 countries during 2000\u20132014 (CONCORD-3)","volume":"80","author":"Matz","year":"2022","journal-title":"Cancer Epidemiol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.1097\/CEJ.0000000000000298","article-title":"Trends in net survival from liver cancer in six European Latin countries: Results from the SUDCAN population-based study","volume":"26","author":"Ferretti","year":"2017","journal-title":"Eur. J. Cancer Prev."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/S1470-2045(19)30456-5","article-title":"Progress in cancer survival, mortality, and incidence in seven high-income countries 1995\u20132014 (ICBP SURVMARK-2): A population-based study","volume":"20","author":"Arnold","year":"2019","journal-title":"Lancet Oncol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.soncn.2017.02.002","article-title":"Cancer Screening and Early Detection in the 21 st Century","volume":"33","author":"Loud","year":"2017","journal-title":"Semin. Oncol. Nurs."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"3753","DOI":"10.1002\/cncr.31581","article-title":"The added value of geriatric screening and assessment for predicting overall survival in older patients with cancer: GA Added to Clinical Information for OS","volume":"124","author":"Kenis","year":"2018","journal-title":"Cancer"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1200\/JCO.2011.38.6359","article-title":"Overall Survival: Patient Outcome, Therapeutic Objective, Clinical Trial End Point, or Public Health Measure?","volume":"30","author":"Saad","year":"2012","journal-title":"J. Clin. Oncol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"e578","DOI":"10.7861\/clinmed.2021-0657","article-title":"Lung cancer for the non-respiratory physician","volume":"21","author":"Mackenzie","year":"2021","journal-title":"Clin. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1610668","DOI":"10.3389\/pore.2022.1610668","article-title":"Comparison of Cancer Survival Trends in Hungary in the Periods 2001\u20132005 and 2011\u20132015 According to a Population-Based Cancer Registry","volume":"28","author":"Kenessey","year":"2022","journal-title":"Pathol. Oncol. Res."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Zhu, X., Zhang, X., Hu, X., Ren, H., Wu, S., Wu, J., Wu, G., Si, X., and Wang, B. (2020). Survival analysis of patients with primary gallbladder cancer from 2010 to 2015: A retrospective study based on SEER data. Medicine, 99.","DOI":"10.1097\/MD.0000000000022292"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1590\/s0004-2803.202000000-32","article-title":"SURVIVAL OF PATIENTS WITH COLORECTAL CANCER IN A CANCER CENTER","volume":"57","author":"Oliveira","year":"2020","journal-title":"Arq. Gastroenterol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/tbj.13502","article-title":"Effect of intraoperative radiotherapy for early breast cancer on 10-year recurrence rates and overall survival","volume":"26","author":"Frasson","year":"2020","journal-title":"Breast J."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Szwiec, M., Marciniak, W., Derkacz, R., Huzarski, T., Gronwald, J., Cybulski, C., D\u0119bniak, T., Jakubowska, A., Lener, M., and Falco, M. (2021). Serum Selenium Level Predicts 10-Year Survival after Breast Cancer. Nutrients, 13.","DOI":"10.3390\/nu13030953"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Russo, A., Peeters, M., Incorvaia, L., and Rolfo, C. (2021). Cutaneous Melanoma and Other Skin Cancers. Practical Medical Oncology Textbook, Springer International Publishing. Available online: https:\/\/link.springer.com\/10.1007\/978-3-030-56051-5_57.","DOI":"10.1007\/978-3-030-56051-5"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"He, Y., Su, Y., Zeng, J., Chong, W., Hu, X., Zhang, Y., and Peng, X. (2022). Cancer-specific survival after diagnosis in men versus women: A pan-cancer analysis. MedComm., 3.","DOI":"10.1002\/mco2.145"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Macintyre, I., Kool, R., Marcq, G., Breau, R., Shayegan, B., Kim, M., Busca, I., Abdi, H., Dawidek, M., and Uy, M. (2023). PD44-02 EFFECT OF GENDER ON SURVIVAL OUTCOMES AFTER TRIMODAL THERAPY FOR MUSCLE-INVASIVE BLADDER CANCER. J. Urol., 209.","DOI":"10.1097\/JU.0000000000003354.02"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.euf.2019.06.001","article-title":"Sex-specific Differences in the Quality of Treatment of Muscle-invasive Bladder Cancer Do Not Explain the Overall Survival Discrepancy","volume":"7","author":"Krimphove","year":"2021","journal-title":"Eur. Urol. Focus"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.ejca.2018.07.005","article-title":"Cancer incidence and mortality patterns in Europe: Estimates for 40 countries and 25 major cancers in 2018","volume":"103","author":"Ferlay","year":"2018","journal-title":"Eur. J. Cancer"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S1470-2045(13)70548-5","article-title":"Childhood cancer survival in Europe 1999\u20132007: Results of EUROCARE-5\u2014A population-based study","volume":"15","author":"Gatta","year":"2014","journal-title":"Lancet Oncol."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Kiss, Z., Szab\u00f3, T.G., Polg\u00e1r, C., Horv\u00e1th, Z., Nagy, P., F\u00e1bi\u00e1n, I., Kov\u00e1cs, V., Surj\u00e1n, G., Barcza, Z., and Kenessey, I. (2024). Revising cancer incidence in a Central European country: A Hungarian nationwide study between 2011\u20132019 based on a health insurance fund database. Front. Oncol., 14.","DOI":"10.3389\/fonc.2024.1393132"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Gyulai, A., Nagy, A., Pataki, V., Tont\u00e9, D., \u00c1d\u00e1ny, R., and Vok\u00f3, Z. (2018). General practitioners can increase participation in cervical cancer screening\u2014A model program in Hungary. BMC Fam. Pract., 19.","DOI":"10.1186\/s12875-018-0755-0"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Pataki, J., Dombr\u00e1di, V., S\u00e1rv\u00e1ry, A., and Sz\u0151ll\u0151si, G.J. (2023). Breast cancer screening and its associating factors among Hungarian women aged 45\u201365: A cross-sectional study based on the European health interview surveys from 2009 to 2019. BMC Public Health, 23.","DOI":"10.1186\/s12889-023-16608-5"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1611635","DOI":"10.3389\/pore.2024.1611635","article-title":"HUNCHEST projects-advancing low-dose CT lung cancer screening in Hungary","volume":"30","author":"Bogos","year":"2024","journal-title":"Pathol. Oncol. Res."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1177\/0969141320968598","article-title":"Modeling costs and benefits of the organized colorectal cancer screening programme and its potential future improvements in Hungary","volume":"28","author":"Gini","year":"2021","journal-title":"J. Med. Screen."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/j.ejca.2012.12.027","article-title":"Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012","volume":"49","author":"Ferlay","year":"2013","journal-title":"Eur. J. Cancer"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Therneau, T.M., and Grambsch, P.M. (2000). Modeling Survival Data: Extending the Cox Model. Springer.","DOI":"10.1007\/978-1-4757-3294-8"},{"key":"ref_28","first-page":"1121","article-title":"Clinical endpoints in oncology\u2014A primer","volume":"11","author":"Delgado","year":"2021","journal-title":"Am. J. Cancer Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1093\/jncimonographs\/lgu024","article-title":"Cancer survival: An overview of measures, uses, and interpretation","volume":"2014","author":"Mariotto","year":"2014","journal-title":"J. Natl. Cancer Inst. Monogr."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/S0140-6736(14)62038-9","article-title":"Global surveillance of cancer survival 1995\u20132009: Analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2)","volume":"385","author":"Allemani","year":"2015","journal-title":"Lancet"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Zhang, C., Zhang, C., Wang, Q., Li, Z., Lin, J., and Wang, H. (2020). Differences in Stage of Cancer at Diagnosis, Treatment, and Survival by Race and Ethnicity Among Leading Cancer Types. JAMA Netw. Open., 3.","DOI":"10.1001\/jamanetworkopen.2020.2950"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Pulumati, A., Pulumati, A., Dwarakanath, B.S., Verma, A., and Papineni, R.V.L. (2023). Technological advancements in cancer diagnostics: Improvements and limitations. Cancer Rep., 6.","DOI":"10.1002\/cnr2.1764"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Vicidomini, G. (2023). Current Challenges and Future Advances in Lung Cancer: Genetics, Instrumental Diagnosis and Treatment. Cancers, 15.","DOI":"10.3390\/cancers15143710"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"293","DOI":"10.4103\/1947-2714.98586","article-title":"Diagnosis and management of gallbladder cancer","volume":"4","year":"2012","journal-title":"N. Am. J. Med. Sci."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.3748\/wjg.v24.i19.2047","article-title":"Challenges in diagnosis of pancreatic cancer","volume":"24","author":"Zhang","year":"2018","journal-title":"World J. Gastroenterol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.jss.2022.05.027","article-title":"Association Between Socioeconomic and Insurance Status and Delayed Diagnosis of Gastrointestinal Cancers","volume":"279","author":"Kim","year":"2022","journal-title":"J. Surg. Res."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/crj.12217","article-title":"Delays for diagnosis and treatment of lung cancers: A systematic review","volume":"10","author":"Vinas","year":"2016","journal-title":"Clin. Respir. J."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1610041","DOI":"10.3389\/pore.2021.1610041","article-title":"Increase in the Length of Lung Cancer Patient Pathway Before First-Line Therapy: A 6-Year Nationwide Analysis From Hungary","volume":"27","author":"Kiss","year":"2021","journal-title":"Pathol. Oncol. Res."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.1002\/cncr.33587","article-title":"The ever-increasing importance of cancer as a leading cause of premature death worldwide","volume":"127","author":"Bray","year":"2021","journal-title":"Cancer"},{"key":"ref_40","unstructured":"(2023, February 26). Source of Hungarian Central Statistical Office Data from 2019. Available online: https:\/\/www.ksh.hu\/docs\/hun\/xstadat\/xstadat_evkozi\/e_wnh001.html."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1053\/j.gastro.2020.02.068","article-title":"Global Burden of 5 Major Types of Gastrointestinal Cancer","volume":"159","author":"Arnold","year":"2020","journal-title":"Gastroenterology"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"756","DOI":"10.3906\/sag-1908-79","article-title":"Efficacy of the population-based pilot colorectal cancer screening, Csongr\u00e1d county, Hungary, 2015","volume":"50","author":"Rutka","year":"2020","journal-title":"Turk. J. Med. Sci."},{"key":"ref_43","unstructured":"(2023, February 26). Webpage of National Public Health Center, Available online: https:\/\/egeszsegvonal.gov.hu\/en\/stay-healthy\/colorectal-screening.html."},{"key":"ref_44","first-page":"209","article-title":"A kolorekt\u00e1lis sz\u0171r\u00e9sek r\u00e9szv\u00e9teli mutat\u00f3i Magyarorsz\u00e1gon 2008\u20132021 k\u00f6z\u00f6tt [Participation indicators of colorectal screenings in Hungary between 2008\u20132021]","volume":"66","author":"Hunyady","year":"2022","journal-title":"Magy. Onkol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"4457","DOI":"10.1007\/s00330-022-08589-7","article-title":"Nationwide lung cancer screening with low-dose computed tomography: Implementation and first results of the HUNCHEST screening program","volume":"32","author":"Monostori","year":"2022","journal-title":"Eur. Radiol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1556\/650.2017.30731","article-title":"Az alacsony d\u00f3zis\u00fa CT-vel v\u00e9gzett t\u00fcd\u0151r\u00e1ksz\u0171r\u00e9s magyarorsz\u00e1gi eg\u00e9szs\u00e9g-gazdas\u00e1gtani elemz\u00e9s\u00e9nek koncepcion\u00e1lis terve [Model concept of the health economic evaluation of low-dose CT lung cancer screening in Hungary]","volume":"158","author":"Barra","year":"2017","journal-title":"Orv. Hetil."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1053\/gast.1997.v112.agast970594","article-title":"Colorectal cancer screening: Clinical guidelines and rationale","volume":"112","author":"Winawer","year":"1997","journal-title":"Gastroenterology"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1056\/NEJMoa1911793","article-title":"Reduced lung-cancer mortality with volume CT screening in a randomized trial","volume":"382","author":"Scholten","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"10","DOI":"10.14740\/wjon1166","article-title":"Epidemiology of pancreatic cancer: Global trends, etiology and risk factors","volume":"10","author":"Rawla","year":"2019","journal-title":"World J. Oncol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3322\/caac.21763","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J. Clin."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.ejca.2019.12.014","article-title":"Impact of colorectal cancer screening on cancer-specific mortality in Europe: A systematic review","volume":"127","author":"Gini","year":"2020","journal-title":"Eur. J. Cancer"},{"key":"ref_52","unstructured":"Paz-Filho, G., Licinio, J., and Wong, M.-L. (2020). Medical screening: Toward a better understanding of its costs, benefits, and harms. Front. Public Health, 8."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Lennon, A.M., Buchanan, A.H., Kinde, I., Warren, A., Honushefsky, A., Cohain, A.T., Ledbetter, D.H., Sanfilippo, F., Sheridan, K., and Rosica, D. (2020). Feasibility of blood testing combined with PET-CT to screen for cancer and guide intervention. Science, 369.","DOI":"10.1126\/science.abb9601"},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Bourgeois, A., Horrill, T., Mollison, A., Stringer, E., Lambert, L.K., and Stajduhar, K. (2024). Barriers to cancer treatment for people experiencing socioeconomic disadvantage in high-income countries: A scoping review. BMC Health Serv. Res., 24.","DOI":"10.1186\/s12913-024-11129-2"},{"key":"ref_55","unstructured":"(2024, February 21). Available online: https:\/\/gutscharity.org.uk\/2023\/01\/less-survivable-cancers-awareness-day-2023\/."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1158\/1055-9965.EPI-11-0246","article-title":"Sex disparities in cancer mortality and survival","volume":"20","author":"Cook","year":"2011","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Jung, K.W., Park, S., Shin, A., Oh, C.M., Kong, H.J., Jun, J.K., and Won, Y.J. (2012). Do female cancer patients display better survival rates compared with males? Analysis of the Korean National Registry data, 2005\u20132009. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0052457"},{"key":"ref_58","unstructured":"GBD 2019 Cancer Risk Factors Collaborators (2022). The global burden of cancer attributable to risk factors, 2010\u20132019: A systematic analysis for the Global Burden of Disease Study 2019. Lancet, 400, 563\u2013591."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.rcl.2012.06.006","article-title":"Lung cancer epidemiology, risk factors, and prevention","volume":"50","author":"Munden","year":"2012","journal-title":"Radiol. Clin. N. Am."},{"key":"ref_60","unstructured":"European Health Information Gateway (2024, February 21). WHO Europe. Age-Standardized Prevalence of Current Tobacco Smoking, Age 15+, WHO Estimates (%), Males. Available online: https:\/\/gateway.euro.who.int\/en\/indicators\/hfa_421-3010-of-regular-daily-smokers-in-the-population-age-15plus\/."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.critrevonc.2005.04.008","article-title":"Prognostic impact of increasing age and co-morbidity in cancer patients: A population-based approach","volume":"55","author":"Houterman","year":"2005","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1200\/JCO.2007.12.8322","article-title":"Age and comorbidity as independent prognostic factors in the treatment of non\u2013small-cell lung cancer: A review of National Cancer Institute of Canada Clinical Trials Group trials","volume":"26","author":"Asmis","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"42","DOI":"10.2478\/raon-2021-0003","article-title":"Trends in population-based cancer survival in Slovenia","volume":"55","author":"Zadnik","year":"2021","journal-title":"Radiol. Oncol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ajhg.2018.11.002","article-title":"Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes","volume":"104","author":"Mavaddat","year":"2019","journal-title":"Am. J. Hum. Genet."},{"key":"ref_65","first-page":"263","article-title":"Incidence of breast cancer subtypes in Belgium: A population-based study","volume":"14","author":"Vandeven","year":"2020","journal-title":"Belg. J. Med. Oncol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/S1470-2045(20)30317-X","article-title":"Estimating the impact of treatment and imaging modalities on 5-year net survival of 11 cancers in 200 countries: A simulation-based analysis","volume":"21","author":"Ward","year":"2020","journal-title":"Lancet Oncol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1111\/jdv.18960","article-title":"Significant improvement in melanoma survival over the last decade: A Hungarian nationwide study between 2011 and 2019","volume":"37","author":"Liszkay","year":"2023","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.hoc.2024.05.016","article-title":"Progress in Immune Checkpoint Inhibitor for Melanoma Therapy","volume":"38","author":"Boutros","year":"2024","journal-title":"Hematol. Oncol. Clin. N. Am."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.canlet.2021.09.034","article-title":"Incidence, mortality, survival, risk factor and screening of colorectal cancer: A comparison among China, Europe, and northern America","volume":"522","author":"Li","year":"2021","journal-title":"Cancer Lett."},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Mamdani, H., Matosevic, S., Khalid, A.B., Durm, G., and Jalal, S.I. (2022). Immunotherapy in Lung Cancer: Current Landscape and Future Directions. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.823618"},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Barclay, N.L., Burn, E., Delmestri, A., Duarte-Salles, T., Golozar, A., Man, W.Y., Tan, E.H., Tietzova, I., Prieto-Alhambra, D., and Newby, D. (2024). Trends in incidence, prevalence, and survival of breast cancer in the United Kingdom from 2000 to 2021. Sci. Rep., 14.","DOI":"10.1101\/2023.11.29.23299179"},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Serd\u00e0-Ferrer, B.C., Sanvisens, A., Fuentes-Raspall, R., Puigdemont, M., Farr\u00e9, X., Vidal-Vila, A., Rispau-Pag\u00e8s, M., Baltasar-Bagu\u00e9, A., and Marcos-Gragera, R. (2023). Significantly reduced incidence and improved survival from prostate cancer over 25 years. BMC Public Health, 23.","DOI":"10.1186\/s12889-023-17440-7"},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Kiss, Z., Mar\u00e1z, A., Rokszin, G., Horv\u00e1th, Z., Nagy, P., F\u00e1bi\u00e1n, I., Kov\u00e1cs, V., Surj\u00e1n, G., Barcza, Z., and Kenessey, I. (2025). Improvements in cancer survival in Hungary: A nationwide epidemiology study between 2011\u20132019 based on a health insurance fund database. Front. Oncol., 15.","DOI":"10.3389\/fonc.2025.1446611"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1249\/MSS.0000000000001937","article-title":"Physical Activity in Cancer Prevention and Survival: A Systematic Review","volume":"51","author":"McTiernan","year":"2019","journal-title":"Med. Sci. Sports Exerc."},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Castro-Espin, C., and Agudo, A. (2022). The Role of Diet in Prognosis among Cancer Survivors: A Systematic Review and Meta-Analysis of Dietary Patterns and Diet Interventions. Nutrients, 14.","DOI":"10.3390\/nu14020348"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1007\/s10552-022-01613-7","article-title":"Adiposity and cancer survival: A systematic review and meta-analysis","volume":"33","author":"Cheng","year":"2022","journal-title":"Cancer Causes Control"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1002\/pon.3077","article-title":"Correlates of continued smoking versus cessation among survivors of smoking-related cancers","volume":"22","author":"Berg","year":"2013","journal-title":"Psychooncology"},{"key":"ref_78","unstructured":"Kufe, D.W., Pollock, R.E., Weichselbaum, R.R., Bast, R.C., Gansler, T.S., Holland, J.F., and Frei, E. (2024, February 21). Incidence of Secondary Cancer, Holland-Frei Cancer Medicine, Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK13212\/."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/17\/10\/1670\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:33:06Z","timestamp":1760031186000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/17\/10\/1670"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,15]]},"references-count":78,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025,5]]}},"alternative-id":["cancers17101670"],"URL":"https:\/\/doi.org\/10.3390\/cancers17101670","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,15]]}}}